T326

CAS No. 1451042-19-5

T326( T 326 | HDAC3 inhibitor T326 )

Catalog No. M11945 CAS No. 1451042-19-5

A potent and selective HDAC3 inhibitor with IC50 of 0.26 uM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    T326
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent and selective HDAC3 inhibitor with IC50 of 0.26 uM.
  • Description
    A potent and selective HDAC3 inhibitor with IC50 of 0.26 uM, with no activity against HDAC1/4/6/8; induces dose-dependent selective increase of NF-κB acetylation in human colon cancer HCT116 cells, induces growth inhibition of cancer cells, and activates HIV gene expression in latent HIV-infected cells; shows promising activity for anticancer and antiviral benefits.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    T 326 | HDAC3 inhibitor T326
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    HDAC
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1451042-19-5
  • Formula Weight
    434.474
  • Molecular Formula
    C21H18N6O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(C1=CC=C(C2=CN(CCC3=CC=CC([N+]([O-])=O)=C3)N=N2)S1)NC4=CC=CC=C4N
  • Chemical Name
    N-(2-aminophenyl)-5-(1-(3-nitrophenethyl)-1H-1,2,3-triazol-4-yl)thiophene-2-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Suzuki T, et al. PLoS One. 2013 Jul 16;8(7):e68669.
molnova catalog
related products
  • Liquiritin apioside

    Liquiritin Apioside is one of the main active components in Suan-Zao-Ren decoction as a treatment for insomnia.

  • Droxinostat

    Droxinostat (NS-41080) is a selective HDAC inhibitor with IC50 of 16.9, 2.47 and 1.46 uM for HDAC3, HDAC6 and HDAC8, respectively.

  • R306465

    R306465 (JNJ-16241199) is an orally active and selective class I histone deacetylase (HDAC 1) inhibitor with an IC50 of 3.3 nM.